Evaluating mesenchymal stem cell therapy for sepsis with preclinical meta-analyses prior to initiating a first-in-human trial

eLife

Volumn 5, Issue NOVEMBER2016, 2016, Pages

  Lalu, Manoj M ^a,b   Sullivan, Katrina J ^b   Mei, Shirley H J ^b   Moher, David ^b,c   Straus, Alexander ^b   Fergusson, Dean A ^b   Stewart, Duncan J ^b,c   Jazi, Mazen ^b,c   Macleod, Malcolm ^d   Winston, Brent ^e   Marshall, John ^f   Hutton, Brian ^b   Walley, Keith R ^g   McIntyre, Lauralyn ^b,c  

^a UNIVERSITY OF OTTAWA   (Canada)

^b OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^c UNIVERSITY OF OTTAWA   (Canada)

^d UNIVERSITY OF EDINBURGH   (United Kingdom)

^e UNIVERSITY OF CALGARY   (Canada)

^f ST MICHAEL'S HOSPITAL   (Canada)

^g UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BIBLIOGRAPHIC DATABASE; CLINICAL TRIAL (TOPIC); COMORBIDITY; CONSTRUCT VALIDITY; DISEASE SEVERITY; FLUID RESUSCITATION; FOLLOW UP; HUMAN; IMMUNOCOMPETENT CELL; INTERNAL VALIDITY; MESENCHYMAL STEM CELL TRANSPLANTATION; META ANALYSIS; MORTALITY; OUTCOME ASSESSMENT; RESUSCITATION; SEPSIS; SYSTEMATIC REVIEW; ANIMAL; MESENCHYMAL STROMA CELL; PATHOLOGY;

ANIMALS; CLINICAL TRIALS AS TOPIC; HUMANS; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; SEPSIS;

EID: 85006511543     PISSN: None     EISSN: 2050084X     Source Type: Journal    
DOI: 10.7554/eLife.17850     Document Type: Article

References (73)

1. Begley CG, Ellis LM. 2012. Drug development: Raise standards for preclinical cancer research. Nature 483:531–533. doi: 10.1038/483531a, PMID: 22460880
2. Bi L-K, Tang B, Zhu B, Xie C-L, Li S, Lin T-X, Hunag J, Zhang W, Zhu J-Y. 2010. Systemic delivery of IL-10 by bone marrow derived stromal cells has therapeutic benefits in sepsis therapy*. Progress in Biochemistry and Biophysics 37:678–685. doi: 10.3724/SP.J.1206.2010.00107
3. Canadian Institutes of Health Research. 2016. RCT Evaluation Criteria and Headings. http://www.cihr-irsc.gc.ca/e/39187.html
4. Chang CL, Leu S, Sung HC, Zhen YY, Cho CL, Chen A, Tsai TH, Chung SY, Chai HT, Sun CK, Yen CH, Yip HK. 2012. Impact of apoptotic adipose-derived mesenchymal stem cells on attenuating organ damage and reducing mortality in rat sepsis syndrome induced by cecal puncture and ligation. Journal of Translational Medicine 10:244. doi: 10.1186/1479-5876-10-244, PMID: 23217183
5. Chao YH, Wu HP, Wu KH, Tsai YG, Peng CT, Lin KC, Chao WR, Lee MS, Fu YC, Fu Y-C. 2014. An increase in CD3 +CD4+CD25+ regulatory T cells after administration of umbilical cord-derived mesenchymal stem cells during sepsis. PLoS One 9:e110338. doi: 10.1371/journal.pone.0110338, PMID: 25337817
6. Cohn LD, Becker BJ. 2003. How meta-analysis increases statistical power. Psychological Methods 8:243–253. doi: 10.1037/1082-989X.8.3.243, PMID: 14596489
7. Collins FS, Tabak LA. 2014. Policy: Nih plans to enhance reproducibility. Nature 505:612–613. doi: 10.1038/505612a
8. Contopoulos-Ioannidis DG, Ntzani E, Ioannidis JP. 2003. Translation of highly promising basic science research into clinical applications. The American Journal of Medicine 114:477–484. doi: 10.1016/S0002-9343(03)00013-5, PMID: 12731504
9. Crossley NA, Sena E, Goehler J, Horn J, van der Worp B, Bath PM, Macleod M, Dirnagl U. 2008. Empirical evidence of bias in the design of experimental stroke studies: a metaepidemiologic approach. Stroke 39:929–934. doi: 10.1161/STROKEAHA.107.498725, PMID: 18239164
10. da Silva Meirelles L, Chagastelles PC, Nardi NB. 2006. Mesenchymal stem cells reside in virtually all post-natal organs and tissues. Journal of Cell Science 119:2204–2213. doi: 10.1242/jcs.02932, PMID: 16684817
11. de Vries RB, Hooijmans CR, Tillema A, Leenaars M, Ritskes-Hoitinga M. 2014. Updated version of the Embase search filter for animal studies. Laboratory Animals 48:88. doi: 10.1177/0023677213494374, PMID: 23836850
12. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A, Prockop D, Horwitz E. 2006. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8:315–317. doi: 10.1080/14653240600855905, PMID: 16923606
13. dos Santos CC, Murthy S, Hu P, Shan Y, Haitsma JJ, Mei SH, Stewart DJ, Liles WC. 2012. Network analysis of transcriptional responses induced by mesenchymal stem cell treatment of experimental sepsis. The American Journal of Pathology 181:1681–1692. doi: 10.1016/j.ajpath.2012.08.009, PMID: 23083833
14. Dyson A, Singer M. 2009. Animal models of sepsis: why does preclinical efficacy fail to translate to the clinical setting? Critical Care Medicine 37:S30–37. doi: 10.1097/CCM.0b013e3181922bd3, PMID: 19104223
15. Food and Drug Administration. 2015. Department of Health and Human Services, Drugs for huamn use: Investigational New Drug Application. https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfCFR/CFRSearch.cfm?fr=312.23
16. Gonzalez-Rey E, Anderson P, Gonzalez MA, Rico L, Buscher D, Delgado M. 2009. Human adult stem cells derived from adipose tissue protect against experimental colitis and sepsis. Gut 58:929–939. doi: 10.1136/gut.2008.168534
17. Grankvist H, Kimmelman J. 2016. How do researchers decide early clinical trials? Medicine, Health Care and Philosophy 19:191–198. doi: 10.1007/s11019-016-9685-6, PMID: 26833467
18. Hall SR, Tsoyi K, Ith B, Padera RF, Lederer JA, Wang Z, Liu X, Perrella MA. 2013. Mesenchymal stromal cells improve survival during sepsis in the absence of heme oxygenase-1: the importance of neutrophils. Stem Cells 31:397–407. doi: 10.1002/stem.1270, PMID: 23132816
19. Hannoush EJ, Sifri ZC, Elhassan IO, Mohr AM, Alzate WD, Offin M, Livingston DH. 2011. Impact of enhanced mobilization of bone marrow derived cells to site of injury. The Journal of Trauma 71:283–291. doi: 10.1097/TA.0b013e318222f380, PMID: 21825928
20. Henderson VC, Kimmelman J, Fergusson D, Grimshaw JM, Hackam DG. 2013. Threats to validity in the design and conduct of preclinical efficacy studies: a systematic review of guidelines for in vivo animal experiments. PLoS Medicine 10:e1001489. doi: 10.1371/journal.pmed.1001489, PMID: 23935460
21. Higgins JPT, Green S. 2009. Cochrane Handbook for Systematic Reviews of Interventions. ed. 5.0.2.
22. Hirst JA, Howick J, Aronson JK, Roberts N, Perera R, Koshiaris C, Heneghan C. 2014. The need for randomization in animal trials: an overview of systematic reviews. PLoS One 9:e98856. doi: 10.1371/journal.pone.0098856, PMID: 24906117
23. Hooijmans CR, Rovers MM, de Vries RB, Leenaars M, Ritskes-Hoitinga M, Langendam MW. 2014. SYRCLE’s risk of bias tool for animal studies. BMC Medical Research Methodology 14:43. doi: 10.1186/1471-2288-14-43, PMID: 24667063
24. Hooijmans CR, Tillema A, Leenaars M, Ritskes-Hoitinga M. 2010. Enhancing search efficiency by means of a search filter for finding all studies on animal experimentation in PubMed. Laboratory Animals 44:170–175. doi: 10.1258/la.2010.009117, PMID: 20551243
25. Horn J, de Haan RJ, Vermeulen M, Luiten PG, Limburg M. 2001. Nimodipine in animal model experiments of focal cerebral ischemia: a systematic review. Stroke 32:2433–2438. doi: 10.1161/hs1001.096009, PMID: 11588338
26. Ioannidis JP. 2005. Why most published research findings are false. PLoS Medicine 2:e124. doi: 10.1371/journal.pmed.0020124, PMID: 16060722
27. Kalra PR, Moon JC, Coats AJ. 2002. Do results of the ENABLE (endothelin antagonist bosentan for lowering cardiac events in heart failure) study spell the end for non-selective endothelin antagonism in heart failure? International Journal of Cardiology 85:195. doi: 10.1016/S0167-5273(02)00182-1, PMID: 12208583
28. Kilkenny C, Browne WJ, Cuthill IC, Emerson M, Altman DG. 2010. Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research. PLoS Biology 8:e1000412. doi: 10.1371/journal.pbio.1000412, PMID: 20613859
29. Kim H, Darwish I, Monroy MF, Prockop DJ, Liles WC, Kain KC. 2014. Mesenchymal stromal (stem) cells suppress pro-inflammatory cytokine production but fail to improve survival in experimental staphylococcal toxic shock syndrome. BMC Immunology 15:1. doi: 10.1186/1471-2172-15-1, PMID: 24423010
30. Kimmelman J, Henderson V. 2016. Assessing risk/benefit for trials using preclinical evidence: a proposal. Journal of Medical Ethics 42:50–53. doi: 10.1136/medethics-2015-102882
31. Kleikers PW, Hooijmans C, Gö b E, Langhauser F, Rewell SS, Radermacher K, Ritskes-Hoitinga M, Howells DW, Kleinschnitz C, Schmidt HH. 2015. A combined pre-clinical meta-analysis and randomized confirmatory trial approach to improve data validity for therapeutic target validation. Scientific Reports 5:13428. doi: 10.1038/srep13428, PMID: 26310318
32. Kola I, Landis J. 2004. Can the pharmaceutical industry reduce attrition rates? Nature Reviews Drug Discovery 3: 711–716. doi: 10.1038/nrd1470, PMID: 15286737
33. Krasnodembskaya A, Samarani G, Song Y, Zhuo H, Su X, Lee J-W, Gupta N, Petrini M, Matthay MA. 2012. Human mesenchymal stem cells reduce mortality and bacteremia in gram-negative sepsis in mice in part by enhancing the phagocytic activity of blood monocytes. AJP: Lung Cellular and Molecular Physiology 302: L1003–L1013. doi: 10.1152/ajplung.00180.2011
34. Lamontagne F, Briel M, Duffett M, Fox-Robichaud A, Cook DJ, Guyatt G, Lesur O, Meade MO. 2010. Systematic review of reviews including animal studies addressing therapeutic interventions for sepsis. Critical Care Medicine 38:2401–2408. doi: 10.1097/CCM.0b013e3181fa0468, PMID: 20890192
35. Landis SC, Amara SG, Asadullah K, Austin CP, Blumenstein R, Bradley EW, Crystal RG, Darnell RB, Ferrante RJ, Fillit H, Finkelstein R, Fisher M, Gendelman HE, Golub RM, Goudreau JL, Gross RA, Gubitz AK, Hesterlee SE, Howells DW, Huguenard J, et al. 2012. A call for transparent reporting to optimize the predictive value of preclinical research. Nature 490:187–191. doi: 10.1038/nature11556, PMID: 23060188
36. Lee DS, Nguyen QT, Lapointe N, Austin PC, Ohlsson A, Tu JV, Stewart DJ, Rouleau JL. 2003. Meta-analysis of the effects of endothelin receptor blockade on survival in experimental heart failure. Journal of Cardiac Failure 9. doi: 10.1054/S1071-9164(03)00125-8, PMID: 14583897
37. Li J, Li D, Liu X, Tang S, Wei F. 2012. Human umbilical cord mesenchymal stem cells reduce systemic inflammation and attenuate LPS-induced acute lung injury in rats. Journal of Inflammation 9:33. doi: 10.1186/1476-9255-9-33
38. Liang ZX, Sun JP, Wang P, Tian Q, Yang Z, Chen LA. 2011. Bone marrow-derived mesenchymal stem cells protect rats from endotoxin-induced acute lung injury. Chinese Medical Journal 124:2715–2722. PMID: 22040430
39. Llovera G, Hofmann K, Roth S, Salas-Pérdomo A, Ferrer-Ferrer M, Perego C, Zanier ER, Mamrak U, Rex A, Party H, Agin V, Fauchon C, Orset C, Haelewyn B, De Simoni MG, Dirnagl U, Grittner U, Planas AM, Plesnila N, Vivien D, et al. 2015. Results of a preclinical randomized controlled multicenter trial (pRCT): Anti-CD49d treatment for acute brain ischemia. Science Translational Medicine 7:299ra121. doi: 10.1126/scitranslmed.aaa9853, PMID: 26246166
40. Luo CJ, Zhang FJ, Zhang L, Geng YQ, Li QG, Hong Q, Fu B, Zhu F, Cui SY, Feng Z, Sun XF, Chen XM. 2014. Mesenchymal stem cells ameliorate sepsis-associated acute kidney injury in mice. Shock 41:123–129. doi: 10.1097/SHK.0000000000000080, PMID: 24169208
41. Macleod MR, Lawson McLean A, Kyriakopoulou A, Serghiou S, de Wilde A, Sherratt N, Hirst T, Hemblade R, Bahor Z, Nunes-Fonseca C, Potluru A, Thomson A, Baginskaite J, Egan K, Vesterinen H, Currie GL, Churilov L, Howells DW, Sena ES. 2015. Risk of bias in reports of in vivo research: a focus for improvement. PLoS Biology 13:e1002273. doi: 10.1371/journal.pbio.1002273, PMID: 26556632
42. Macleod MR, van der Worp HB, Sena ES, Howells DW, Dirnagl U, Donnan GA. 2008. Evidence for the efficacy of NXY-059 in experimental focal cerebral ischaemia is confounded by study quality. Stroke 39:2824–2829. doi: 10.1161/STROKEAHA.108.515957, PMID: 18635842
43. McCann SK, Irvine C, Mead GE, Sena ES, Currie GL, Egan KE, Macleod MR, Howells DW. 2014. Efficacy of antidepressants in animal models of ischemic stroke: a systematic review and meta-analysis. Stroke 45:3055–3063. doi: 10.1161/STROKEAHA.114.006304, PMID: 25184357
44. Mei SH, Haitsma JJ, Dos Santos CC, Deng Y, Lai PF, Slutsky AS, Liles WC, Stewart DJ, Stewart DJ. 2010. Mesenchymal stem cells reduce inflammation while enhancing bacterial clearance and improving survival in sepsis. American Journal of Respiratory and Critical Care Medicine 182:1047. doi: 10.1164/rccm.201001-0010OC, PMID: 20558630
45. Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group. 2009. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Medicine 6:e1000097. doi: 10.1371/journal.pmed.1000097
46. Moonesinghe R, Khoury MJ, Janssens AC. 2007. Most published research findings are false-but a little replication goes a long way. PLoS Medicine 4:e28. doi: 10.1371/journal.pmed.0040028, PMID: 17326704
47. Mouncey PR, Osborn TM, Power GS, Harrison DA, Sadique MZ, Grieve RD, Jahan R, Harvey SE, Bell D, Bion JF, Coats TJ, Singer M, Young JD, Rowan KM, ProMISe Trial Investigators. 2015. Trial of early, goal-directed resuscitation for septic shock. New England Journal of Medicine 372:1301–1311. doi: 10.1056/NEJMoa1500896, PMID: 25776532
48. National Institutes of Health. 2015. Principles and Guidelines for Reporting Preclinical Research. http://www.nih.gov/research-training/rigor-reproducibility/principles-guidelines-reporting-preclinical-research
49. Németh K, Leelahavanichkul A, Yuen PS, Mayer B, Parmelee A, Doi K, Robey PG, Leelahavanichkul K, Koller BH, Brown JM, Hu X, Jelinek I, Star RA, Mezey E. 2009. Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production. Nature Medicine 15:42–49. doi: 10.1038/nm.1905, PMID: 19098906
50. Osuchowski MF, Remick DG, Lederer JA, Lang CH, Aasen AO, Aibiki M, Azevedo LC, Bahrami S, Boros M, Cooney R, Cuzzocrea S, Jiang Y, Junger WG, Hirasawa H, Hotchkiss RS, Li XA, Radermacher P, Redl H, Salomao R, Soebandrio A, et al. 2014. Abandon the mouse research ship? Not just yet!. Shock 41:463–475. doi: 10.1097/SHK.0000000000000153, PMID: 24569509
51. Pan Z, Trikalinos TA, Kavvoura FK, Lau J, Ioannidis JP. 2005. Local literature bias in genetic epidemiology: an empirical evaluation of the Chinese literature. PLoS Medicine 2:e124. doi: 10.1371/journal.pmed.0020334, PMID: 16285839
52. Peake SL, Delaney A, Bailey M, Bellomo R, Cameron PA, Cooper DJ, Higgins AM, Holdgate A, Howe BD, Webb SA, Williams P, ARISE Investigators, ANZICS Clinical Trials Group. 2014. Goal-directed resuscitation for patients with early septic shock. The New England Journal of Medicine 371:1496–1506. doi: 10.1056/NEJMoa1404380, PMID: 25272316
53. Pedrazza L, Lunardelli A, Luft C, Cruz CU, de Mesquita FC, Bitencourt S, Nunes FB, de Oliveira JR. 2014. Mesenchymal stem cells decrease splenocytes apoptosis in a sepsis experimental model. Inflammation Research 63:719–728. doi: 10.1007/s00011-014-0745-1, PMID: 24888322
54. Reagan-Shaw S, Nihal M, Ahmad N. 2008. Dose translation from animal to human studies revisited. The FASEB Journal 22:659–661. doi: 10.1096/fj.07-9574LSF, PMID: 17942826
55. Rochefort GY, Delorme B, Lopez A, Hérault O, Bonnet P, Charbord P, Eder V, Domenech J. 2006. Multipotential mesenchymal stem cells are mobilized into peripheral blood by hypoxia. Stem Cells 24:2202–2208. doi: 10.1634/stemcells.2006-0164, PMID: 16778152
56. Rooke EDM, Vesterinen HM, Sena ES, Egan KJ, Macleod MR. 2011. Dopamine agonists in animal models of Parkinson’s disease: a systematic review and meta-analysis. Parkinsonism & Related Disorders 17:313–320. doi: 10.1016/j.parkreldis.2011.02.010
57. Scott S, Kranz JE, Cole J, Lincecum JM, Thompson K, Kelly N, Bostrom A, Theodoss J, Al-Nakhala BM, Vieira FG, Ramasubbu J, Heywood JA. 2008. Design, power, and interpretation of studies in the standard murine model of ALS. Amyotrophic Lateral Sclerosis 9:4–15. doi: 10.1080/17482960701856300, PMID: 18273714
58. Sena ES, Currie GL, McCann SK, Macleod MR, Howells DW. 2014. Systematic reviews and meta-analysis of preclinical studies: why perform them and how to appraise them critically. Journal of Cerebral Blood Flow & Metabolism 34:737–742. doi: 10.1038/jcbfm.2014.28, PMID: 24549183
59. Sena ES, van der Worp HB, Bath PM, Howells DW, Macleod MR. 2010. Publication bias in reports of animal stroke studies leads to major overstatement of efficacy. PLoS Biology 8:e1000344. doi: 10.1371/journal.pbio.1000344, PMID: 20361022
60. Seok J, Warren HS, Cuenca AG, Mindrinos MN, Baker HV, Xu W, Richards DR, McDonald-Smith GP, Gao H, Hennessy L, Finnerty CC, López CM, Honari S, Moore EE, Minei JP, Cuschieri J, Bankey PE, Johnson JL, Sperry J, Nathens AB, et al. 2013. Genomic responses in mouse models poorly mimic human inflammatory diseases. PNAS 110:3507–3512. doi: 10.1073/pnas.1222878110, PMID: 23401516
61. Sepúlveda JC, Tomé M, Fernández ME, Delgado M, Campisi J, Bernad A, González MA. 2014. Cell senescence abrogates the therapeutic potential of human mesenchymal stem cells in the lethal endotoxemia model. Stem Cells 32:1865. doi: 10.1002/stem.1654, PMID: 24496748
62. Shuaib A, Lees KR, Lyden P, Grotta J, Davalos A, Davis SM, Diener HC, Ashwood T, Wasiewski WW, Emeribe U, SAINT II Trial Investigators. 2007. NXY-059 for the treatment of acute ischemic stroke. New England Journal of Medicine 357:562–571. doi: 10.1056/NEJMoa070240, PMID: 17687131
63. Spees JL, Lee RH, Gregory CA. 2016. Mechanisms of mesenchymal stem/stromal cell function. Stem Cell Research & Therapy 7:125. doi: 10.1186/s13287-016-0363-7, PMID: 27581859
64. Sterne JA, Sutton AJ, Ioannidis JP, Terrin N, Jones DR, Lau J, Carpenter J, Rü cker G, Harbord RM, Schmid CH, Tetzlaff J, Deeks JJ, Peters J, Macaskill P, Schwarzer G, Duval S, Altman DG, Moher D, Higgins JP. 2011. Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomized controlled trials. BMJ 343:d4002. doi: 10.1136/bmj.d4002, PMID: 21784880
65. Stevenson EK, Rubenstein AR, Radin GT, Wiener RS, Walkey AJ. 2014. Two decades of mortality trends among patients with severe sepsis: a comparative meta-analysis*. Critical Care Medicine 42:625–631. doi: 10.1097/CCM.0000000000000026, PMID: 24201173
66. Steward O, Popovich PG, Dietrich WD, Kleitman N. 2012. Replication and reproducibility in spinal cord injury research. Experimental Neurology 233:597–605. doi: 10.1016/j.expneurol.2011.06.017, PMID: 22078756
67. U.S. Department of Health and Human Services, Food and Drug Administration. 2013. Guidance for Industry: Preclinical Assessment of Investigational Cellular and Gene Therapy Products. http://www.fda.gov/downloads/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/Guidances/CellularandGeneTherapy/UCM376521.pdf
68. van der Worp HB, Sena ES, Donnan GA, Howells DW, Macleod MR. 2007. Hypothermia in animal models of acute ischaemic stroke: a systematic review and meta-analysis. Brain 130:3063–3074. doi: 10.1093/brain/awm083, PMID: 17478443
69. Walter J, Ware LB, Matthay MA. 2014. Mesenchymal stem cells: mechanisms of potential therapeutic benefit in ARDS and sepsis. The Lancet Respiratory Medicine 2:1016–1026. doi: 10.1016/S2213-2600(14)70217-6, PMID: 25465643
70. Yang JF, Cao HC, Pan QL, Yu J, Li J, Li LJ. 2015. Mesenchymal stem cells from the human umbilical cord ameliorate fulminant hepatic failure and increase survival in mice. Hepatobiliary & Pancreatic Diseases International 14:186–193. doi: 10.1016/S1499-3872(15)60354-X, PMID: 25865692
71. Zhao X, Liu D, Gong W, Zhao G, Liu L, Yang L, Hou Y. 2014. The toll-like receptor 3 ligand, poly(I:C), improves immunosuppressive function and therapeutic effect of mesenchymal stem cells on sepsis via inhibiting MiR-143. Stem Cells 32:521–533. doi: 10.1002/stem.1543, PMID: 24105952
72. Zhao Y, Yang C, Wang H, Li H, Du J, Gu W, Jiang J. 2013. Therapeutic effects of bone marrow-derived mesenchymal stem cells on pulmonary impact injury complicated with endotoxemia in rats. International Immunopharmacology 15:246–253. doi: 10.1016/j.intimp.2012.12.008, PMID: 23273653
73. Zhou R, Li Z, He C, Li R, Xia H, Li C, Xiao J, Chen ZY. 2014. Human umbilical cord mesenchymal stem cells and derived hepatocyte-like cells exhibit similar therapeutic effects on an acute liver failure mouse model. PLoS One 9:e104392. doi: 10.1371/journal.pone.0104392, PMID: 25101638